Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-05190457 in Alcoholism
NCT02039349Phase 1Completed
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Jan 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of PF-05190457 in alcohol dependence (3 arms), sponsored by National Institute on Alcohol Abuse and Alcoholism. Primary endpoints: Number of adverse events at 3 days and Total concentration of the drug at 3 days. Started Jan 2014; status: completed.
02
Drugs
PF-05190457
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT02039349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02039349.